Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 48

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems

Müller, Anna, Grein, Fabian, Otto, Andreas, Gries, Kathrin, Orlov, Dmitriy, Zarubaev, Vladimir, Girard, Myriam, Sher, Xinwei, Shamova, Olga, Roemer, Terry, François, Patrice, Becher, Dörte, Schneider, Tanja, Sahl, Hans-Georg·2018·International Journal of Medical Microbiology
DOI 10.1016/j.ijmm.2017.12.002
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijmm.2017.12.002

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 116

  1. Balibar, 2009, The mevalonate pathway of Staphylococcus aureus, J. Bacteriol., 191, 851, 10.1128/JB.01357-08 · DOI
  2. Bayer, 2006, Low-level resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein 1 in vitro associated with qacA gene carriage is independent of multidrug efflux pump activity, Antimicrob. Agents Chemother., 50, 2448, 10.1128/AAC.00028-06 · DOI
  3. Bayer, 2013, Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall, Ann. N. Y. Acad. Sci., 1277, 139, 10.1111/j.1749-6632.2012.06819.x · DOI · Paper page
  4. Berti, 2012, Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics, Antimicrob. Agents Chemother., 56, 5046, 10.1128/AAC.00502-12 · DOI
  5. Berti, 2015, Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics, Antimicrob. Agents Chemother., 59, 2799, 10.1128/AAC.04990-14 · DOI
  6. Bertsche, 2011, Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation, Antimicrob. Agents Chemother., 55, 3922, 10.1128/AAC.01226-10 · DOI
  7. Bertsche, 2013, Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates, PLoS One, 8, e67398, 10.1371/journal.pone.0067398 · DOI
  8. Camargo, 2008, Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype, Antimicrob. Agents Chemother., 52, 4289, 10.1128/AAC.00417-08 · DOI
  9. Charbonnier, 2005, A generic approach for the design of whole-genome oligoarrays, validated for genomotyping, deletion mapping and gene expression analysis on Staphylococcus aureus, BMC Genom., 6, 95, 10.1186/1471-2164-6-95 · DOI
  10. Churchill, 2004, Using ANOVA to analyze microarray data, Biotechniques, 37, 173, 10.2144/04372TE01 · DOI · Paper page
  11. Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science, 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
  12. Cotroneo, 2008, Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus, Antimicrob. Agents Chemother., 52, 2223, 10.1128/AAC.01410-07 · DOI
  13. Cui, 2000, Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50, Antimicrob. Agents Chemother., 44, 2276, 10.1128/AAC.44.9.2276-2285.2000 · DOI · Paper page
  14. Cui, 2003, Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus, J. Clin. Microbiol., 41, 5, 10.1128/JCM.41.1.5-14.2003 · DOI · Paper page
  15. Cui, 2006, Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-Intermediate staphylococcus aureus, Antimicrob. Agents Chemother., 50, 1079, 10.1128/AAC.50.3.1079-1082.2006 · DOI · Paper page
  16. Derichs, 2014, Pedobacter nutrimenti sp. nov., isolated from chilled food, Int. J. Syst. Evol. Microbiol., 64, 1310, 10.1099/ijs.0.058677-0 · doi:10.1099/ijs.0.058677-0
  17. Dowhan, 2012, Molecular genetic and biochemical approaches for defining lipid-dependent membrane protein folding. Biochim. Biophys, Acta, 1818, 1097
  18. Dubrac, 2008, Tearing down the wall: peptidoglycan metabolism and the WalK/WalR (YycG/YycF) essential two-component system, Adv. Exp. Med. Biol., 631, 214, 10.1007/978-0-387-78885-2_15 · doi:10.1007/978-0-387-78885-2_15
  19. Dubrac, 2008, A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway, Mol. Microbiol., 70, 1307, 10.1111/j.1365-2958.2008.06483.x · DOI · Paper page
  20. Ernst, 2009, The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion, PLoS Pathog., 5, e1000660, 10.1371/journal.ppat.1000660 · DOI · Paper page
  21. Falord, 2011, Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathways, PLoS One, 6, e21323, 10.1371/journal.pone.0021323 · DOI · Paper page
  22. Fischer, 2011, Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach, J. Antimicrob. Chemother., 66, 1696, 10.1093/jac/dkr195 · DOI
  23. Foster, 2014, Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus, Nat. Rev. Microbiol., 12, 49, 10.1038/nrmicro3161 · DOI · Paper page
  24. Fournier, 2000, A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus, J. Bacteriol., 182, 3955, 10.1128/JB.182.14.3955-3964.2000 · DOI · Paper page
  25. Fournier, 2001, The two-component system ArlS-ArlR is a regulator of virulence gene expression in Staphylococcus aureus, Mol. Microbiol., 41, 247, 10.1046/j.1365-2958.2001.02515.x · DOI · Paper page
  26. Fridman, 2013, Two unique phosphorylation-driven signaling pathways crosstalk in Staphylococcus aureus to modulate the cell-wall charge: stk1/Stp1 meets GraSR, Biochemistry, 52, 7975, 10.1021/bi401177n · DOI
  27. Friedman, 2006, Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus, Antimicrob. Agents Chemother., 50, 2137, 10.1128/AAC.00039-06 · DOI · Paper page
  28. Götz, 2013, Both terminal oxidases contribute to fitness and virulence during organ-specific Staphylococcus aureus colonization, MBio, 4, 10.1128/mBio.00976-13 · DOI
  29. Geiger, 2008, The virulence regulator Sae of Staphylococcus aureus: promoter activities and response to phagocytosis-related signals, J. Bacteriol., 190, 3419, 10.1128/JB.01927-07 · DOI · Paper page
  30. Gustafson, 1992, Autolysis of methicillin-resistant and –susceptible Staphylococcus aureus, Antimicrob. Agents Chemother., 36, 566, 10.1128/AAC.36.3.566 · doi:10.1128/aac.36.3.566
  31. Hachmann, 2009, Genetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin, Antimicrob. Agents Chemother., 53, 1598, 10.1128/AAC.01329-08 · DOI · Paper page
  32. Hachmann, 2011, Reduction in membrane phosphatidylglycerol content leads to daptomycin resistance in Bacillus subtilis, Antimicrob. Agents Chemother., 55, 4326, 10.1128/AAC.01819-10 · DOI
  33. Hammer, 2013, Two heme-dependent terminal oxidases power Staphylococcus aureus organ-specific colonization of the vertebrate host, MBio, 4, 10.1128/mBio.00241-13 · DOI · Paper page
  34. Herbert, 2007, Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci, PLoS Pathog., 3, e102, 10.1371/journal.ppat.0030102 · DOI · Paper page
  35. Herbert, 2010, Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates, Infect. Immun., 78, 2877, 10.1128/IAI.00088-10 · DOI · Paper page
  36. Hessling, 2013, Global proteome analysis of vancomycin stress in Staphylococcus aureus, Int. J. Med. Microbiol., 303, 624, 10.1016/j.ijmm.2013.08.014 · DOI
  37. Hyo, 2013, Thickening of the cell wall in macrolide-resistant Staphylococcus aureus, Med. Mol. Morphol., 46, 217, 10.1007/s00795-013-0027-y · doi:10.1007/s00795-013-0027-y
  38. Hyyryläinen, 2010, Penicillin-binding protein folding is dependent on the PrsA peptidyl-prolyl cis-trans isomerase in Bacillus subtilis, Mol. Microbiol., 77, 108, 10.1111/j.1365-2958.2010.07188.x · DOI
  39. Johnson, 2006, Daptomycin in the treatment of skin, soft-tissue and invasive infections due to Gram-positive bacteria, Future Microbiol., 1, 255, 10.2217/17460913.1.3.255 · DOI
  40. Jones, 2008, Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding, Antimicrob. Agents Chemother., 52, 269, 10.1128/AAC.00719-07 · DOI · Paper page
  41. Jousselin, 2012, The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 56, 3629, 10.1128/AAC.06264-11 · DOI
  42. Kafala, 1997, Isolation of the Staphylococcus aureus hemCDBL gene cluster coding for early steps in heme biosynthesis, Gene, 199, 231, 10.1016/S0378-1119(97)00372-7 · DOI
  43. Kelley, 2011, Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure, J Antimicrob. Chemother., 66, 1057, 10.1093/jac/dkr066 · DOI
  44. Koessler, 2006, Use of oligoarrays for characterization of community-onset methicillin-resistant Staphylococcus aureus, J. Clin. Microbiol., 44, 1040, 10.1128/JCM.44.3.1040-1048.2006 · doi:10.1128/jcm.44.3.1040-1048.2006
  45. Kraus, 2008, The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses, BMC Microbiol., 8, 85, 10.1186/1471-2180-8-85 · DOI
  46. Kuroda, 2003, Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus, Mol. Microbiol., 49, 807, 10.1046/j.1365-2958.2003.03599.x · DOI · Paper page
  47. Lee, 2010, Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment, Antimicrob. Agents Chemother., 54, 4038, 10.1128/AAC.00533-10 · DOI
  48. Li, 2009, Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics (Oxford, England), 25, 1754, 10.1093/bioinformatics/btp324 · DOI · Paper page
  49. Li, 2007, The antimicrobial peptide-sensing system aps of Staphylococcus aureus, Mol. Microbiol., 66, 1136, 10.1111/j.1365-2958.2007.05986.x · DOI · Paper page
  50. Liang, 2006, Inactivation of a two-component signal transduction system, SaeRS, eliminates adherence and attenuates virulence of Staphylococcus aureus, Infect. Immun., 74, 4655, 10.1128/IAI.00322-06 · DOI · Paper page
  51. Lipski, 1997, Identification of heterotrophic bacteria isolated from ammonia-supplied experimental biofilters, Syst. Appl. Microbiol., 20, 448, 10.1016/S0723-2020(97)80014-8 · doi:10.1016/s0723-2020(97)80014-8
  52. Lipski, 2012, Aquamicrobium ahrensii sp. nov. and Aquamicrobium segne sp. nov., isolated from experimental biofilters, Int. J. Syst. Evol. Microbiol., 62, 2511, 10.1099/ijs.0.038224-0 · doi:10.1099/ijs.0.038224-0
  53. Lu, 2009, Structure-based mechanism of lipoteichoic acid synthesis by Staphylococcus aureus LtaS, Proc. Natl. Acad. Sci. U. S. A., 106, 1584, 10.1073/pnas.0809020106 · DOI
  54. Müller, 2014, Deletion of membrane-associated Asp23 leads to upregulation of cell wall stress genes in Staphylococcus aureus, Mol. Microbiol., 93, 1259, 10.1111/mmi.12733 · DOI
  55. MacCoss, 2003, A correlation algorithm for the automated quantitative analysis of shotgun proteomics data, Anal. Chem., 75, 6912, 10.1021/ac034790h · DOI · Paper page
  56. Marshall, 1981, Pigments of Staphylococcus aureus, a series of triterpenoid carotenoids, J. Bacteriol., 147, 900, 10.1128/jb.147.3.900-913.1981 · DOI · Paper page
  57. Mascher, 2006, Intramembrane-sensing histidine kinases: a new family of cell envelope stress sensors in Firmicutes bacteria, FEMS Microbiol. Lett., 264, 133, 10.1111/j.1574-6968.2006.00444.x · DOI · Paper page
  58. McKenna, 2010, The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data, Genome Res., 20, 1297, 10.1101/gr.107524.110 · DOI · Paper page
  59. Meehl, 2007, Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 51, 2679, 10.1128/AAC.00209-07 · DOI · Paper page
  60. Mehta, 2012, VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 56, 92, 10.1128/AAC.00432-10 · DOI · Paper page
  61. Mindich, 1971, Induction of staphylococcus aureus lactose permease in the absence of glycerolipid synthesis, Proc. Natl. Acad. Sci. U. S. A., 68, 420, 10.1073/pnas.68.2.420 · DOI
  62. Mishra, 2013, Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 57, 1082, 10.1128/AAC.02182-12 · DOI
  63. Mishra, 2009, Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 53, 2312, 10.1128/AAC.01682-08 · DOI · Paper page
  64. Mishra, 2011, In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates, Antimicrob. Agents Chemother., 55, 4012, 10.1128/AAC.00223-11 · DOI
  65. Mishra, 2012, Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content, PLoS One, 7, e43958, 10.1371/journal.pone.0043958 · DOI · Paper page
  66. Mishra, 2012, Differential adaptations of methicillin-resistant staphylococcus aureus to serial In vitro passage in daptomycin: evolution of daptomycin resistance and role of membrane carotenoid content and fluidity, Int. J. Microbiol., 2012, 683450, 10.1155/2012/683450 · DOI
  67. Mohedano, 2005, Evidence that the essential response regulator YycF in Streptococcus pneumoniae modulates expression of fatty acid biosynthesis genes and alters membrane composition, J. Bacteriol., 187, 2357, 10.1128/JB.187.7.2357-2367.2005 · DOI
  68. Morikawa, 2001, Overexpression of sigma factor, sigma(B), urges Staphylococcus aureus to thicken the cell wall and to resist beta-lactams, Biochem. Biophys. Res. Commun., 288, 385, 10.1006/bbrc.2001.5774 · doi:10.1006/bbrc.2001.5774
  69. Muller, 2016, Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains, Proc. Natl. Acad. Sci. U. S. A., 113, E7077, 10.1073/pnas.1611173113 · DOI · Paper page
  70. Muthaiyan, 2008, Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization, Antimicrob. Agents Chemother., 52, 980, 10.1128/AAC.01121-07 · DOI · Paper page
  71. Nusbaum, 2009, Sensitive, specific polymorphism discovery in bacteria using massively parallel sequencing, Nat. Methods, 6, 67, 10.1038/nmeth.1286 · DOI
  72. Ortwine, 2013, Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the seesaw effect: taking advantage of the back door left open?, Drug Resist. Updat e, 16, 73, 10.1016/j.drup.2013.10.002 · DOI
  73. Otto, 2010, Systems-wide temporal proteomic profiling in glucose-starved Bacillus subtilis, Nat. Commun., 1, 137, 10.1038/ncomms1137 · DOI · Paper page
  74. Palmer, 2011, Genetic basis for daptomycin resistance in enterococci, Antimicrob. Agents Chemother., 55, 3345, 10.1128/AAC.00207-11 · DOI · Paper page
  75. Park, 2008, A quantitative analysis software tool for mass spectrometry-based proteomics, Nat Methods, 5, 319, 10.1038/nmeth.1195 · DOI · Paper page
  76. Parsons, 2011, Metabolic basis for the differential susceptibility of gram-positive pathogens to fatty acid synthesis inhibitors, Proc. Natl. Acad. Sci. U. S. A., 108, 15378, 10.1073/pnas.1109208108 · DOI · Paper page
  77. Peleg, 2012, Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus, PLoS One, 7, e28316, 10.1371/journal.pone.0028316 · DOI · Paper page
  78. Pelz, 2005, Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus, J. Biol. Chem., 280, 32493, 10.1074/jbc.M505070200 · DOI · Paper page
  79. Peschel, 2006, The co-evolution of host cationic antimicrobial peptides and microbial resistance, Nat. Rev. Microbiol., 4, 529, 10.1038/nrmicro1441 · DOI · Paper page
  80. Peschel, 1999, Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides, J. Biol. Chem., 274, 8405, 10.1074/jbc.274.13.8405 · DOI · Paper page
  81. Qamar, 2012, Dual roles of FmtA in Staphylococcus aureus cell wall biosynthesis and autolysis, Antimicrob. Agents Chemother., 56, 3797, 10.1128/AAC.00187-12 · DOI
  82. Rao, 2009, Enzymatic investigation of the Staphylococcus aureus type I signal peptidase SpsB – implications for the search for novel antibiotics, FEBS J., 276, 3222, 10.1111/j.1742-4658.2009.07037.x · doi:10.1111/j.1742-4658.2009.07037.x
  83. Rick, 1998, Characterization of the lipid-carrier involved in the synthesis of enterobacterial common antigen (ECA) and identification of a novel phosphoglyceride in a mutant of Salmonella typhimurium defective in ECA synthesis, Glycobiology, 8, 557, 10.1093/glycob/8.6.557 · doi:10.1093/glycob/8.6.557
  84. Rogasch, 2006, Influence of the two-component system SaeRS on global gene expression in two different Staphylococcus aureus strains, J. Bacteriol., 188, 7742, 10.1128/JB.00555-06 · DOI · Paper page
  85. Rose, 2008, Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations, Antimicrob. Agents Chemother., 52, 3061, 10.1128/AAC.00102-08 · DOI
  86. Rubinchik, 2011, Mechanism of action and limited cross-resistance of new lipopeptide MX-2401, Antimicrob. Agents Chemother., 55, 2743, 10.1128/AAC.00170-11 · DOI
  87. Rubio, 2011, Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus, Antimicrob. Agents Chemother., 55, 364, 10.1128/AAC.00429-10 · DOI
  88. Sakoulas, 2002, Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin, Antimicrob. Agents Chemother., 46, 1492, 10.1128/AAC.46.5.1492-1502.2002 · DOI · Paper page
  89. Sakoulas, 2006, Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin, Antimicrob. Agents Chemother., 50, 1581, 10.1128/AAC.50.4.1581-1585.2006 · DOI · Paper page
  90. Sass, 2009, Native graS mutation supports the susceptibility of Staphylococcus aureus strain SG511 to antimicrobial peptides, Int. J. Med. Microbiol., 299, 313, 10.1016/j.ijmm.2008.10.005 · doi:10.1016/j.ijmm.2008.10.005
  91. Sass, 2010, Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci, Infect. Immun., 78, 2793, 10.1128/IAI.00688-09 · DOI · Paper page
  92. Sauermann, 2008, Daptomycin: a review 4 years after first approval, Pharmacology, 81, 79, 10.1159/000109868 · DOI
  93. Scherl, 2006, Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers, BMC Genom., 7, 296, 10.1186/1471-2164-7-296 · DOI
  94. Schneider, 2010, Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II, Science (New York, N. Y.), 328, 1168, 10.1126/science.1185723 · DOI · Paper page
  95. Sieradzki, 1997, Suppression of beta-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics, J. Antimicrob. Chemother., 39, 47, 10.1093/jac/39.suppl_1.47 · DOI
  96. Sieradzki, 2003, Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus, J. Bacteriol., 185, 7103, 10.1128/JB.185.24.7103-7110.2003 · DOI · Paper page
  97. Sievers, 2010, Changing the phospholipid composition of Staphylococcus aureus causes distinct changes in membrane proteome and membrane-sensory regulators, Proteomics, 10, 1685, 10.1002/pmic.200900772 · DOI
  98. Silverman, 2003, Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus, Antimicrob. Agents Chemother., 47, 2538, 10.1128/AAC.47.8.2538-2544.2003 · DOI · Paper page
  99. Song, 2013, Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies, PLoS One, 8, e58469, 10.1371/journal.pone.0058469 · DOI
  100. Straus, 2006, Mode of action of the new antibiotic for gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides, Biochim. Biophys. Acta, 1758, 1215, 10.1016/j.bbamem.2006.02.009 · DOI · Paper page
  101. Türck, 2012, Purification and activity testing of the full-length YycFGHI proteins of Staphylococcus aureus, PLoS One, 7, e30403, 10.1371/journal.pone.0030403 · DOI
  102. Utaida, 2003, Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon, Microbiology (Reading, Engl.), 149, 2719, 10.1099/mic.0.26426-0 · DOI · Paper page
  103. Vignaroli, 2011, Striking \seesaw effect\ between daptomycin nonsusceptibility and beta-lactam susceptibility in Staphylococcus haemolyticus, Antimicrob. Agents Chemother., 55, 2495, 10.1128/AAC.00224-11 · DOI
  104. Voyich, 2009, The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus, J. Infect. Dis., 199, 1698, 10.1086/598967 · DOI · Paper page
  105. Wörmann, 2011, Proteolytic cleavage inactivates the Staphylococcus aureus lipoteichoic acid synthase, J. Bacteriol., 193, 5279, 10.1128/JB.00369-11 · DOI
  106. Wakeman, 2012, Menaquinone biosynthesis potentiates haem toxicity in Staphylococcus aureus, Mol. Microbiol., 86, 1376, 10.1111/mmi.12063 · DOI · Paper page
  107. Walker, 2013, The Staphylococcus aureus ArlRS two-component system is a novel regulator of agglutination and pathogenesis, PLoS Pathog., 9, e1003819, 10.1371/journal.ppat.1003819 · DOI
  108. Wecke, 2009, Daptomycin versus Friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responses, Antimicrob. Agents Chemother., 53, 1619, 10.1128/AAC.01046-08 · DOI
  109. Weidenmaier, 2005, DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model, Infect. Immun., 73, 8033, 10.1128/IAI.73.12.8033-8038.2005 · DOI · Paper page
  110. Wu, 2003, Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces, Antimicrob. Agents Chemother., 47, 3407, 10.1128/AAC.47.11.3407-3414.2003 · DOI · Paper page
  111. Wu, 2012, The two-component signal transduction system ArlRS regulates Staphylococcus epidermidis biofilm formation in an ica-dependent manner, PLoS One, 7, e40041, 10.1371/journal.pone.0040041 · DOI
  112. Yang, 2009, Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus, J. Infect. Dis., 200, 1916, 10.1086/648473 · DOI · Paper page
  113. Yang, 2009, Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains, Antimicrob. Agents Chemother., 53, 2636, 10.1128/AAC.01415-08 · DOI · Paper page
  114. Yang, 2010, Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the \seesaw effect\), Antimicrob. Agents Chemother., 54, 3161, 10.1128/AAC.00487-10 · DOI
  115. Yang, 2012, The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides, Infect. Immun., 80, 74, 10.1128/IAI.05669-11 · DOI
  116. Zhao, 2012, Staphylococcus aureus methicillin-resistance factor fmtA is regulated by the global regulator SarA, PLoS One, 7, e43998, 10.1371/journal.pone.0043998 · doi:10.1371/journal.pone.0043998

Cited by

See all 48

Metadata

Authors
Müller, A., Grein, F., Otto, A., Gries, K., Orlov, D., Zarubaev, V., Girard, M., Sher, X., Shamova, O., Roemer, T., François, P., Becher, D., Schneider, T., & Sahl, H.-G.
ORCID
Venue
International Journal of Medical Microbiology
Publisher
Elsevier BV
Published
2018-04
Volume
308
Issue
3
Pages
335-348
ISSN
1438-4221
DOI
10.1016/j.ijmm.2017.12.002
Cited by
48
References
5
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • Deutsche Forschungsgemeinschaft (FOR854 SCHN1284/1-2)
  • Rheinische Friedrich-Wilhelms-Universität Bonn
  • Deutsches Zentrum für Infektionsforschung

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems. https://app.cochat.ai/papers/10.1016/j.ijmm.2017.12.002
The paper
Müller, A., Grein, F., Otto, A., Gries, K., Orlov, D., Zarubaev, V., Girard, M., Sher, X., Shamova, O., Roemer, T., François, P., Becher, D., Schneider, T., & Sahl, H.-G. (2018). Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems. International Journal of Medical Microbiology. https://doi.org/10.1016/j.ijmm.2017.12.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.